Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies.
暂无分享,去创建一个
C. Gwaltney | K. Dragnev | K. Skaltsa | J. Goldschmidt | S. Morris | Y. Pritchett | J. Weiss | D. Daniel | Z. Andrić | J. Antal